| Safety and Efficacy of Saxagliptin Plus Insulin With or Without Metformin (NCT00757588) | AstraZeneca | 2008-11-01 |
| Exploratory Study to Assess the Pharmacokinetics of AZD5985 (NCT00799331) | AstraZeneca | 2008-11-01 |
| Relative Bioavailability of Phase II and Phase III Formulations of AZD0530 (NCT00771979) | AstraZeneca | 2008-11-01 |
| NIS-observe Treatment Efficacy in Maintaining Symptoms Control in Moderate/Severe Asthma With Symbicort SMART (NCT00785733) | AstraZeneca | 2008-11-01 |
| A Proof of Concept Study With 0.5% Roflumilast Cream in Patients With Mild to Moderate Plaque Psoriasis (NCT00746434) | AstraZeneca | 2008-11-01 |
| A Placebo Controlled 4 Week Proof of Concept Study With 0.5% Roflumilast Cream in Patients With Mild Atopic Dermatitis (RO-2351-001-EM) (NCT00746382) | AstraZeneca | 2008-11-01 |
| Study of the Efficacy and Safety of Quetiapine Fumarate Extended Release (Seroquel XR) (NCT00779506) | AstraZeneca | 2008-11-01 |
| AZD6765 Oral Single Ascending Dose/Multiple Ascending Dose (SAD/MAD) (NCT00963365) | AstraZeneca | 2008-11-01 |
| Comparison of the Bioavailability of Fenofibric Acid and Rosuvastatin From 5/45 mg Strength of ABT-143 Relative to That From the Coadministration of ABT-335 (Fenofibric Acid) 45 mg and Rosuvastatin Calcium 5 mg (NCT00826358) | AstraZeneca | 2008-11-01 |
| Safety and Efficacy of Exenatide Once Weekly Injection Versus Metformin, Dipeptidyl Peptidase-4 Inhibitor, or Thiazolidinedione as Monotherapy in Drug-Naive Patients With Type 2 Diabetes (DURATION-4) (NCT00676338) | AstraZeneca | 2008-11-01 |
| In-practice Evaluation of Atacand 16mg Antihypertensive Effect (NCT00802542) | AstraZeneca | 2008-11-01 |
| Study to Investigate Safety and Tolerability Single Ascending Doses of AZD4017 (NCT00791752) | AstraZeneca | 2008-11-01 |
| Safety and Efficacy Study Comparing ABT-143 to Simvastatin in Subjects With Elevated Levels of Low Density Lipoprotein Cholesterol ("Bad Cholesterol") and Triglycerides (NCT00812955) | AstraZeneca | 2008-11-01 |
| Extension Study of Protocol DFA102 to Examine the Long-Term Safety, Tolerability, and Effect on Body Weight of Pramlintide Administered in Combination With Metreleptin (NCT00819234) | AstraZeneca | 2008-11-01 |
| AZD6765 Single and Multiple Ascending Dose Study in Healthy Male and Female Japanese and Caucasian Subjects (NCT00785915) | AstraZeneca | 2008-11-01 |
| A Study to Compare the Efficacy, Safety and Tolerability of Selomax With Its Individual Components (NCT00819104) | AstraZeneca | 2008-11-01 |
| Retrospective Treatment Pattern Survey for the Patient With and Without History of Stroke (NCT00785057) | AstraZeneca | 2008-11-01 |
| 14729-D9831C00002- 1 Month Biopsy Study (NCT00766415) | AstraZeneca | 2008-11-01 |
| Partial Response to Proton Pump Inhibitors (PPI) Treatment: The Cost to Society and the Burden to the Patient - a Study in the US (NCT00795093) | AstraZeneca | 2008-11-01 |
| Phase I Comparative Bioavailability Study (NCT00777582) | AstraZeneca | 2008-10-27 |
| Survey to Describe Impact of Reflux Disease on Everyday Life in GERD Patients Before and After 4 Weeks Treatment. (NCT00786773) | AstraZeneca | 2008-10-01 |
| AZD8075 Single Ascending Dose Study (NCT00787072) | AstraZeneca | 2008-10-01 |
| Real Life Effectiveness in Patients With Not Optimally Controlled Asthma (NCT00784953) | AstraZeneca | 2008-10-01 |
| AZD8529 Multiple Ascending Dose Study in Healthy Subjects (NCT00765492) | AstraZeneca | 2008-10-01 |
| AZD7325 Single Ascending Dose Study in Healthy Male Japanese Subjects (NCT00769899) | AstraZeneca | 2008-10-01 |
| Non-Interventional Study to Evaluate Effect of Zoladex In EndometrioSIS (NCT00761683) | AstraZeneca | 2008-10-01 |
| Exploratory Study of Coronary Flow Reserve Measurements, a Non-Invasive Method for Coronary Function Measurements (NCT00783042) | AstraZeneca | 2008-10-01 |
| Addition Of Exenatide To Insulin Glargine In Type 2 Diabetes Mellitus (NCT00765817) | AstraZeneca | 2008-10-01 |
| General Practice Research Database Seroquel XR Safety Study (NCT01447082) | AstraZeneca | 2008-10-01 |
| Assess Pharmacokinetics, Safety and Tolerability in Healthy Chinese Volunteers After Oral Doses of Saxagliptin (NCT00770302) | AstraZeneca | 2008-10-01 |
| A Study on Intima Media Thickness (IMT) in Middle-aged Subjects (NCT00784264) | AstraZeneca | 2008-10-01 |
| To Evaluate Safety and Tolerability After Multiple Oral Doses of AZD1656 in Type 2 Diabetes Patients on Top of Metformin (NCT00774553) | AstraZeneca | 2008-10-01 |
| Study of Uptake, Break Down and Elimination of an Investigational Drug in Healthy Volunteers (NCT00777361) | AstraZeneca | 2008-10-01 |
| Faslodex Registry: Fulvestrant in Current Clinical Practice (NCT00735215) | AstraZeneca | 2008-10-01 |
| Four Dimensions in Schizophrenia (NCT00782899) | AstraZeneca | 2008-10-01 |
| A Project Ensuring Quality and Cooperation in the Chronic Obstructive Pulmonary Disease (COPD) Treatment (NCT00772733) | AstraZeneca | 2008-10-01 |
| Evaluation of the Pharmacokinetic Interaction Between Candesartan and Felodipine After Ingestion of a Specific Meal (NCT00905333) | AstraZeneca | 2008-10-01 |
| Cediranib in Combination With Lomustine Chemotherapy in Recurrent Glioblastoma (NCT00777153) | AstraZeneca | 2008-10-01 |
| AZD6765 Severe Major Depressive Disorder (MDD) IV (NCT00781742) | AstraZeneca | 2008-10-01 |
| Antidepressant Incomplete Response Depression (NCT00782964) | AstraZeneca | 2008-10-01 |
| Assess Safety, Tolerability and PK of AZD3199 in Japanese (NCT00772759) | AstraZeneca | 2008-10-01 |
| A Phase II , Placebo-controlled Study to Assess Efficacy of 28 Day Oral AZD9668 in Patients With Cystic Fibrosis (NCT00757848) | AstraZeneca | 2008-10-01 |
| Safety of Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus Treated With Thiazolidinedione Alone or Thiazolidinedione in Combination With Metformin (NCT00753896) | AstraZeneca | 2008-10-01 |
| Awareness of Chinese National Adult Lipid Treatment Guideline (2007) and Rate of Patients Achieving the Treatment Goal (NCT00781560) | AstraZeneca | 2008-10-01 |
| Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes (NCT00736879) | AstraZeneca | 2008-09-22 |
| Phase I/II Study of AZD2281 Given in Combination With Paclitaxel in Metastatic Triple Negative Breast Cancer (NCT00707707) | AstraZeneca | 2008-09-15 |
| Study of the Effect of Rifampicin on the Pharmacokinetics (PK) of Multiple Doses of Cediranib in Patients With Solid Tumours (NCT00750841) | AstraZeneca | 2008-09-09 |
| Observation of Change in Clinical Global Impression Scores in Schizophrenia Patients Receiving Seroquel XR Treatment (NCT00758251) | AstraZeneca | 2008-09-01 |
| To Evaluate Safety and Tolerability After Multiple Oral Doses of AZD1656 in Type 2 Diabetes Patients on Top of Insulin (NCT00768105) | AstraZeneca | 2008-09-01 |
| Study in Schizophrenic In-patients Treated With Quetiapine Prolong or Oral Risperidone at Flexible Dose (NCT00660595) | AstraZeneca | 2008-09-01 |
| A Phase IIa Study Assessing the Effects of AZD1236 on Biomarkers in Chronic Obstructive Pulmonary Disease (COPD) Patients (NCT00758706) | AstraZeneca | 2008-09-01 |
| Tolerability/PoP Study in Allergic Rhinitis After Intranasal Administration of AZD8848 (NCT00770003) | AstraZeneca | 2008-09-01 |
| Prevalence of EED and Quality of Life Evaluated by Gastroesophageal Reflux Disease (GERD)-Q in Korean GERD Patients (NCT00768196) | AstraZeneca | 2008-09-01 |
| Phase I Study to Evaluate Bioavailability of Naproxen as PN400 Compared to Naproxen as Proxen S and Naprosyn E (NCT00761501) | AstraZeneca | 2008-09-01 |
| Study to Assess Safety, Tolerability and Pharmacokinetics After Single Doses of AZD2516 to Healthy Volunteers (NCT00754715) | AstraZeneca | 2008-09-01 |
| Investigate the Safety Tolerability and Pharmacokinetics of Multiple Doses of AZD1236 (NCT00767052) | AstraZeneca | 2008-09-01 |
| Assess the Efficacy, Safety and Tolerability of Gefitinib (Iressa® 250mg) as Maintenance Therapy in Locally Advanced or Metastatic (Stage IIIB/IV) Non Small Cell Lung Cancer (NSCLC) (NCT00770588) | AstraZeneca | 2008-09-01 |
| Study to Assess the Safety, Tolerability and Pharmacokinetics After Multiple Doses of AZD2066 in Japanese Subjects (NCT00766012) | AstraZeneca | 2008-09-01 |
| Symptoms and Management Strategies in Gastroesophageal Reflux Disease (GERD) (NCT00768443) | AstraZeneca | 2008-09-01 |
| A Phase II , Placebo-controlled Study to Assess Efficacy of 28 Day Oral AZD9668 in Patients With Bronchiectasis (NCT00769119) | AstraZeneca | 2008-09-01 |
| A Sedation/Cognition/EEG Study Using AZD6280 and Comparator (NCT00750802) | AstraZeneca | 2008-09-01 |
| Safety/Tolerability Study With AZD1236 in Chronic Obstructive Pulmonary Disease (COPD) Patients (NCT00758459) | AstraZeneca | 2008-09-01 |
| To Evaluate the Effect of Food on the Pharmacokinetics (PK) of AZD0328 (NCT00752830) | AstraZeneca | 2008-09-01 |
| National Survey on Asthma (NCT00770250) | AstraZeneca | 2008-09-01 |
| AZD3355 Dose-escalation Study in Healthy Males (NCT00757419) | AstraZeneca | 2008-09-01 |
| One Month Dose Response Study of AZD1981 in Asthma Patients Uncontrolled on Inhaled Steroids (NCT00758589) | AstraZeneca | 2008-09-01 |
| The Performance of Patient Support Program in Early Stage Breast Cancer (NCT00769080) | AstraZeneca | 2008-09-01 |
| Ciclesonide for the Treatment of Airway Hyperresponsiveness (NCT00826969) | AstraZeneca | 2008-09-01 |
| China Registration Study in Patients With Skin Infections (NCT00772447) | AstraZeneca | 2008-09-01 |
| Study in Taiwanese Subjects Identified as CYP2C19 Poor and Extensive Metabolizers Receiving Rosuvastatin (NCT00766025) | AstraZeneca | 2008-09-01 |
| AZD8529 Single Ascending Dose Study (NCT00755378) | AstraZeneca | 2008-09-01 |
| Assessment of Efficacy of AZD2281 in Platinum Sensitive Relapsed Serous Ovarian Cancer (NCT00753545) | AstraZeneca | 2008-08-28 |
| Open-Label, Multicenter Extension Study for Patients Completing Treatment Phase of a Rigel-Sponsored R935788 Studies (NCT00805467) | AstraZeneca | 2008-08-01 |
| ZD4054 (Zibotentan) Phase II Non-Small Cell Lung Cancer Study (NCT00745875) | AstraZeneca | 2008-08-01 |
| A Study to Assess Co-Administered AZD9056 (Steady State) and Simvastatin (Single Dose) in Healthy Volunteers (NCT00736606) | AstraZeneca | 2008-08-01 |
| Assess Safety, Tolerability and Pharmacokinetic (PK) of AZD1704 in Healthy Japanese Male and Non-Fertile Female Volunteers (NCT00736788) | AstraZeneca | 2008-08-01 |
| DCE CT/MRI Scanning Study in Patients With Solid Tumours (AstraZeneca and Royal Marsden Hospital Imaging Study) (NCT00748891) | AstraZeneca | 2008-08-01 |
| A Study to Evaluate Safety and Tolerability After Single Oral Dosing of AZD1656 in Japanese Healthy Volunteers (NCT00741689) | AstraZeneca | 2008-08-01 |
| AZD5672 Absolute Bioavailability Study (NCT00746837) | AstraZeneca | 2008-08-01 |
| Phase 1 Study of the Effect of Ketoconazole on the PK of Multiple Doses of Cediranib in Patients With Solid Tumours (NCT00750425) | AstraZeneca | 2008-08-01 |
| The Use of a Forecasting System for Predicting Exacerbations of COPD (NCT00788645) | AstraZeneca | 2008-08-01 |
| Effect of Exenatide on Abdominal Fat Distribution in Patients With Type 2 Diabetes Pretreated With Metformin (NCT00701935) | AstraZeneca | 2008-08-01 |
| An Observational Study of Adherence to Anastrozole in Early Breast Cancer Treatment (NCT00737009) | AstraZeneca | 2008-08-01 |
| An Interaction Study With Digoxin and AZD1305 (NCT00712465) | AstraZeneca | 2008-08-01 |
| Non-interventional Study -Observe Treatment Efficacy in Maintaining Symptoms Control in Schizophrenia With Seroquel XR (NCT00750087) | AstraZeneca | 2008-08-01 |
| Comparison of the Effect of Exenatide Versus Sitagliptin on 24-hour Average Glucose in Patients With Type 2 Diabetes on Metformin or a Thiazolidinedione (NCT00729326) | AstraZeneca | 2008-08-01 |
| An Open Label Non-Interventional Evaluation of the Effect of Adjuvant Hormonal Treatment of Postmenopausal Women Wih Early Breast Cancer With Aromatase Inhibitors on Bone Mineral Density and Bone Fracture Rate in Daily Practice (NCT00767585) | AstraZeneca | 2008-08-01 |
| Single-dose Crossover Study to Investigate Pharmacodynamics of AZD3199 (NCT00736489) | AstraZeneca | 2008-08-01 |
| A Study to Evaluate Safety, Tolerability and P-Glucose After Multiple Ascending Oral Doses of AZD1656 in Type 2 Diabetes (NCT00747175) | AstraZeneca | 2008-08-01 |
| Investigate the Effect of AZD1305 on Patients With Left Ventricular Dysfunction (NCT00748982) | AstraZeneca | 2008-08-01 |
| Multiple Ascending Doses (MAD) of AZD3199 Given Once Daily as Inhaled Formulation Via Turbuhaler to Healthy Men (NCT00713271) | AstraZeneca | 2008-08-01 |
| Study to Compare the Bioavailability of ABT-335 and Rosuvastatin From ABT-143 Capsules Relative to That From Co-administration of ABT-335 and Rosuvastatin for the 5/45mg Dosage Form. (NCT00728780) | AstraZeneca | 2008-08-01 |
| Phase I, Open-label, Dose-escalation, Safety and PK Study of AZD6918 (NCT00733031) | AstraZeneca | 2008-08-01 |
| Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single Doses of AZD8566. (NCT00749333) | AstraZeneca | 2008-08-01 |
| Single and Multiple Ascending Doses of AZD1981 in Japan (NCT00698282) | AstraZeneca | 2008-08-01 |
| Dose-finding Study Comparing Efficacy and Safety of a PARP Inhibitor Against Doxil in BRCA+ve Advanced Ovarian Cancer (NCT00628251) | AstraZeneca | 2008-07-30 |
| Phase II Study of AZD2281 in Patients With Known BRCA Mutation Status or Recurrent High Grade Ovarian Cancer or Patients With Known BRCA Mutation Status/ Triple Neg Breast Cancer (NCT00679783) | AstraZeneca | 2008-07-08 |
| An Interaction Study of Ketoconazole/Verapamil Versus AZD1305 (NCT00707551) | AstraZeneca | 2008-07-01 |
| Safety Study of AZD5672 in Renally Impaired Subjects (NCT00715702) | AstraZeneca | 2008-07-01 |
| Investigating Safety, Tolerability and Pharmakinetics When Giving Single and Fractionated Doses of AZD3241 to Healthy Volunteers (NCT00729443) | AstraZeneca | 2008-07-01 |